Letters and drug alerts sent to healthcare professionals in October 2019

2019-11-21T14:56:49+00:00

Letters were sent about quadrivalent influenza vaccine, fentanyl ampoules, and Volibris (ambrisentan), and a number of pharmacy-level recalls were issued for ranitidine-containing products. Other alerts issued in October 201…